DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS
نویسندگان
چکیده
منابع مشابه
Atp inside Cells . . . and Outside
KE N E W A RD One of the fi rst and most enduring facts most students learn in biology class is that all living cells use a small molecule called adenosine triphosphate (ATP) as fuel. That universal energy currency drives the biological reactions that allow cells to function and life to fl ourish—making ATP a crucial player in the biological world. Less commonly known, however, is that what is ...
متن کاملIn-Between Space, Dialectic of Inside and Outside in Architecture
Defining space by dividing it to inside and outside is one of human’s ways to recognize his positionin environment. Architecture is created to response to this need for inside/outside spaces. Design of inside and outsideSpaces and relation between them always has been one of necessities for definition and limitation of human livingspaces, but little attention to relation of this two spatial rea...
متن کاملThe new oral anticoagulants.
Although their first application in clinical practice occurred in the 1940s, vitamin K antagonists remain the only form of oral anticoagulant medication approved for long-term use. Although the available vitamin K antagonists are highly effective for the prevention and/or treatment of most thrombotic disease, the significant interpatient and intrapatient variability in dose-response, the narrow...
متن کاملReversal of new oral anticoagulants.
Although the options for therapeutic modalities such as chemotherapy and antibiotics have flourished, anticoagulant management has remained stagnant since the first agents were developed during World War II. Traditional anticoagulants widely used to treat thromboembolic disease include heparin-based drugs and warfarin. These drugs are cumbersome to administer. They have a narrow therapeutic win...
متن کاملNew oral anticoagulants in development.
Although currently available anticoagulants are effective for the prevention and treatment of thromboembolic disorders, they have several drawbacks. Low-molecular-weight heparins and fondaparinux produce a predictable level of anticoagulation that obviates the need for coagulation monitoring, but they must be given parenterally, which renders them inconvenient for long-term use. Vitamin K antag...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rational Pharmacotherapy in Cardiology
سال: 2017
ISSN: 2225-3653,1819-6446
DOI: 10.20996/1819-6446-2017-13-5-716-724